ASPLUND T ET AL: "HYALURONAN RECEPTORS ARE EXPRESSED ON HUMAN MALIGNANT MESOTHELIOMA CELLS BUT NOT ON NORMAL MESOTHELIAL CELLS", CANCER RESEARCH, vol. 54, no. 16, August 1994 (1994-08), pages 4516-4523, XP000872939, ISSN: 0008-5472 (B1)

CHAD E GALER ET AL: "Hyaluronic acidpaclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid-mediated mechanism", ORAL ONCOLOGY, vol. 47, no. 11, 28 July 2011 (2011-07-28) , pages 1039-1047, XP028320587, ISSN: 1368-8375, DOI: 10.1016/J.ORALONCOLOGY.2011.07.029 [retrieved on 2011-08-04] (B1)

EDMOND AUZENNE ET AL: "Hyaluronic acid-paclitaxel : antitumor efficacy against CD44(+) human ovarian carcinoma xenografts", NEOPLASIA, vol. 9, no. 6, 2007, pages 479-486, XP008139171, ISSN: 1522-8002, DOI: 10.1593/NEO.07229 (B1)

LOURDES CORTES-DERICKS ET AL: "CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives", RESPIRATORY RESEARCH, vol. 18, no. 1, ART. 58, 12 April 2017 (2017-04-12), pages 1-12, XP055750863, ISSN: 1465-993X, DOI: 10.1186/s12931-017-0546-5 (B1)

LUO YI ET AL: "A Hyaluronic Acid-Taxol Antitumor Bioconjugate Targeted to Cancer Cells", BIOMACROMOLECULES, vol. 1, no. 2, 13 June 2000 (2000-06-13), pages 208-218, XP002601147, ISSN: 1525-7797, DOI: 10.1021/BM000283N [retrieved on 2000-03-25] cited in the application (B1)

WO-A2-2004/035629 (B1)

RAJENDAR K. MITTAPALLI ET AL: "Paclitaxel-Hyaluronic NanoConjugates Prolong Overall Survival in a Preclinical Brain Metastases of Breast Cancer Model", MOLECULAR CANCER THERAPEUTICS, vol. 12, no. 11, 6 November 2013 (2013-11-06), pages 2389-2399, XP055750970, ISSN: 1535-7163, DOI: 10.1158/1535-7163.MCT-13-0132 (B1)

S. J. LEE ET AL: "Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma", CLINICAL CANCER RESEARCH, vol. 18, no. 15, August 2012 (2012-08), pages 4114-4121, XP055750858, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-11-3250 (B1)

SASAI MASAO ET AL: "Novel Hyaluronan Formulation Enhances the Efficacy of Boron Neutron Capture Therapy for Murine Mesothelioma", ANTICANCER RESEARCH, vol. 36, no. 3, 14 March 2016 (2016-03-14) , pages 907-912, XP055809687, Retrieved from the Internet: URL:https://ar.iiarjournals.org/content/an ticanres/36/3/907.full.pdf> (B1)

US-A1- 2010 173 865 (B1)

WO-A1-2020/084525 (B1)

MIRANDA P. WEEN ET AL: "Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 12, no. 2, 31 January 2011 (2011-01-31), pages 1009-1029, XP055042928, DOI: 10.3390/ijms12021009 (B1)